UNSPSC 51131615: Fondaparinux

This classification denotes an anticoagulant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J177FOW5JL. European Medicines Agency schedules Fondaparinux in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25907. Fondaparinux generally arises in the molecular formula C31H43N3NA10O49S8. The term 'fondaparinux' is a Hazardous Substances Data Bank designation. As of Q4 2014, FONDAPARINUX remains the US FDA Preferred Term for this commodity.

Fondaparinux bears US NLM identifiers UMLS ID C0701492 and NCI Concept Code C73142. SMILES: S(=O)(=O)(O)NC1C(OS(=O)(=O)O)C(OC2OC(C(OC3OC(C(O)C(O)C3NS(=O)(=O)O)COS(=O)(=O)O)C(O)C2O)C(=O)O)C(OC1OC1C(O)C(OS(=O)(=O)O)C(OC1C(=O)O)OC1C(O)C(NS(=O)(=O)O)C(OC1COS(=O)(=O)O)OC)COS(=O)(=O)O.[NA].[NA].[NA].[NA].[NA].[NA].[NA].[NA].[NA].[NA].

UNSPSC 51131615 Fondaparinux is a Commodity code that names a specific anticoagulant pharmaceutical product, but the sole recent state and local opportunity on record—a Sourcewell cooperative purchasing RFP for law enforcement equipment posted May 12, 2026, with a response deadline of June 16, 2026—shows no connection to fondaparinux procurement. The mismatch suggests either a data-tagging error or that fondaparinux purchasing by state and local governments does not currently generate solicitation activity tracked in public opportunity feeds. State and local health departments, correctional agencies, and public hospitals would be the logical buyers of fondaparinux as a pharmaceutical input, but no such solicitations appear in the recent record.

The Sourcewell RFP (Solicitation 061626) represents cooperative purchasing authority managed by Sourcewell, a Minnesota local government unit, on behalf of participating entities including Franklin, Grant, Grays Harbor, Chelan, and Yakima Counties in Washington, along with schools, tribal governments, and other public entities across the United States and Canada. The actual scope—law enforcement equipment—falls entirely outside the fondaparinux commodity definition, indicating the code assignment does not reflect the work being solicited. No set-aside designations, award values, or budget ranges are disclosed in the available solicitation materials. Without recent opportunities that align with the pharmaceutical scope of the code, pursue or watch decisions should rest on direct outreach to state Medicaid agencies, correctional health services, and public hospital procurement offices rather than on posted solicitation activity under this code.